newsfilter
← Latest News
Business Wire·

LENSAR Reports First Quarter 2024 Results and Provides Business Update

Total Revenue increased 28% and Procedure volume increased 25% over the first quarter of 2023 Increased ALLY® Adaptive Cataract Treatment System installed base to 65 systems LENSAR, Inc. (NASDAQ:LNSR) ("LENSAR"